Concern regarding ACE inhibitors and ARB exposure leading to greater expression of ACE2 is particularly strong given that patients on these medications often have characteristics and comorbidities such as CVD, hypertension, and diabetes that each may make them more susceptible to SARS-CoV-2, as previously described earlier in this review [102]. The gene discussed is ACE2; the disease is Hypertension.